Contrast agents
MRI Contrast Agents
Article REF: AF6818 V1
Contrast agents
MRI Contrast Agents

Authors : Jean-François MORFIN, Jean-Claude BELOEIL, Éva TÓTH

Publication date: January 10, 2014, Review date: April 1, 2018 | Lire en français

Logo Techniques de l'Ingenieur You do not have access to this resource.
Request your free trial access! Free trial

Already subscribed?

2. Contrast agents

2.1 Context

MRI entered the clinical arena in 1980 and has become a widely democratized diagnostic technique. In fact, over 75 million examinations are carried out worldwide every year. The advantages of MRI are that it is non-invasive, does not use ionizing radiation, has excellent spatial resolution (millimeters for clinical examinations and micrometers for research), and can be applied to any part of the body. However, in some areas, contrast may not be sufficient. This is why compounds have been developed to overcome this problem.

MRI contrast agents first appeared in 1988 in the form of a gadolinium(III)-DTPA (Diethylenetriamine Pentaacetic Acid) complex. Since then, they have taken on considerable importance, with almost 40% of MRI examinations involving...

You do not have access to this resource.
Logo Techniques de l'Ingenieur

Exclusive to subscribers. 97% yet to be discovered!

You do not have access to this resource. Click here to request your free trial access!

Already subscribed?


Article included in this offer

"Healthcare technologies"

( 123 articles )

Complete knowledge base

Updated and enriched with articles validated by our scientific committees

Services

A set of exclusive tools to complement the resources

View offer details
Contact us